Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial ...

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug ...